Platelet Serotonin Uptake in Panic Disorder: Comparison with Normal Controls and the Effect of Treatment

Reference

• FileS The neurochemistry of anxiety. 1n: Burrows, GD Norman, TR Davies, B, eds. Drugs in Psychiatry, Volume 2 Antianxiety Agents. Amsterdam: Elsevier Science Publishers, 1984: 13–32
   Google Scholar
• Thiebot M. Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines? Pharmacology Biochemistry and Behaviour 1986;24:1471–1477 .
   PubMed Web of Science ®Google Scholar
• Johnston A, File SE. 5-HT and anxiety: promises and pitfalls. Pharmacology Biochemistry and Behaviour 1986;24:1467–1470 .
   PubMed Web of Science ®Google Scholar
• Trulson ME, Arasteh K. Buspirone decreases the activity of 5-hydroxytryptamine-containing dorsal raphe neurons in-vitro. Journal of Pharmacy and Pharmacology 1986;38:380–382 .
   PubMedGoogle Scholar
• Peroutka S, Snyder S. 3H-mianserin-differential labelling of serotonin-2 and histamine receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics 1981;216:142–148 .
   PubMed Web of Science ®Google Scholar
• Judd FK, Norman TR, Burrows GD. Pharmacological treatment of panic disorder. International Clinical Psychopharmacology 1986; 1:3–16 .
   PubMed Web of Science ®Google Scholar
• Bressa GM, Marini S, Gregori S. Serotonin S2 receptor blockade and generalised anxiety disorders. A double-blind study on ritanserin and lorazepam. International Joumal of Pharmacological Research 1978; VII: 111–119 .
   Google Scholar
• Chamey DS, Heninger GR. Serotonin function in panic disorders. The effects of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Archives of General Psychiatry 1986;43:1059–1065 .
   Google Scholar
• Van Praag HM, Lemus G, Kahn R. Hormonal probes of central serotonin activity: do they really exist? Biological Psychiatry 1987;22:86–98 .
   PubMedGoogle Scholar
• Udhe T, Berrettini W, Roy-Byrne P, Boulenger J-P. Post RM. Platelet 3H-Imipramine binding in patients with panic disorder. Biological Psychiatry 2252–58 .
   Google Scholar
• Schneider L, Munjack D, Severson J, Palmer R. Platelet 3H-imipramine binding in generalised anxiety disorder, panic disorder and agoraphobia with panic attacks. Biological Psychiatry 1987;22:59–66 .
   PubMed Web of Science ®Google Scholar
• Nutt DJ, Frazer S. Platelet binding studies in panic disorder. Journal of Affective Disorders 1987;12:7–11 .
   PubMed Web of Science ®Google Scholar
• Innis RB, Chamey DS, Heninger GR. Differential 3H-imipramine binding in patients with panic disorder and depression. Psychiatry Research 1987;21:33–41 .
   PubMed Web of Science ®Google Scholar
• Norman TR, Judd FK. Gregory, M James, RH. Kimber NM, Mc-Intyre IM. Burrows GD. Platelet serotonin uptake in panic disorder. Journal of Affective Disorders 1986;11:69–72 .
   Google Scholar
• Spitzer, R Williams, JBW. Structured Clinical Interview for DSM-111, Biometrics Research Department, New York State Psychiatric Institute. New York, 1983.
   Google Scholar
• Hamilton M. A rating scale for anxiety. British Journal of Medical Psychology 1959;32:50–55 .
   PubMed Web of Science ®Google Scholar
• Lingjaerde O. Platelet uptake and storage of serotonin. In: Essman WB, ed. Serotonin in Health and Disease Volume 4. New York: Spectrum Publications, 1977: 139–199 .
   Google Scholar
• SPSS Inc. SPSS-X Users Guide. Second edition. New York: Mc-Craw-Hill Book Company, 1986.
   Google Scholar
• Wirz-Justice A, Richter R. Seasonality in biochemical determinations. Psychiatry Research 1979; 153–60 .
   Google Scholar
• Lingjaerde O. Effect of benzodiazepines on uptake and efflux of serotonin in human blood platelets in virro. In: Garattini, S Mussini, E Randall, LO, TheBenzodiazepines. New York: Raven Press 1973:225–233 .
   Google Scholar
• Swade C, Milln P, Coppen A. The effect of nitrazepam and other hypnotics on platelet 5-HT uptake. British Journal of Clinical Pharmacology 1981; 12:588–590 .
   PubMedGoogle Scholar
• Ross SB, Aperia B, Beck-Friis J, Jansa S, Wetterberg L, Aberg A. Inhibition of 5-hydroxytryptamine uptakeinhuman platelets by antidepressant agents in vivo. Psychopharmacology 1988;67:1–7 .
   Google Scholar
• Norman TR, Burrows GD. Anxiety and the benzodiazepine receptor. Progress in Brain Research 1986;65:73–90 .
   PubMedGoogle Scholar
• Lingjaerde O. Lactate-induced panic attacks: possible involvement of serotonin re-uptake stimulation. Acta Psychiatric Scandinavica 1985; 72:206–208 .
   Google Scholar
• Frohman CE Rainey JM Warner K Bates S Pohl RB. Plasma lactate and pyruvate levels in panic disorder patients and control subjects. In: Burrows GD, Norman TR, Dennerstein L, eds. Clinical and Pharmacological Studies in Psychiatric Disorders. London: John Libbey and Company, 1985:129–135 .
   Google Scholar
• Evans L, Schneider P, Ross-Lee L, Wiltshire B, Eadie M, Kenardy J, Hoey H. Plasma serotonin levels in agoraphobia. American Journal of Psychiatry 1985;142:267.
   PubMed Web of Science ®Google Scholar
• Balon R, Pohl R, Yeragini V, Rainey J. Oxenkrug GF. Platelet serotonin levels in panic disorder. Acta Psychiatrica Scandinavica 1987;75:315–317 .
   PubMed Web of Science ®Google Scholar
• Stahl S. The human platelet: a diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Archives of General Psychiatry 1977;34:509–516 .
   PubMed Web of Science ®Google Scholar
• Redmond DE, Huang YH. New evidence for a locus ceruleusnorepinephrine connection with anxiety. Life Science 1979;25:2 149–2 161.
   Google Scholar